Paper26480907
High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients.
Geyer LB and 3 others. Braz J Otorhinolaryngol, 2015. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients. Papers, record 26480907. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26480907
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aminoglycosides | Major topic |
| Anti-Bacterial Agents | Major topic |
| Cystic Fibrosis | Major topic |
| Hearing Loss | Major topic |
| Otoacoustic Emissions, Spontaneous | Major topic |
| Adolescent | |
| Audiometry, Pure-Tone | |
| Case-Control Studies | |
| Child | |
| Cross-Sectional Studies | |
| Female | |
| Humans | |
| Male | |
| Young Adult |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10526861 | Effects of chronic tobramycin treatment on distortion product otoacoustic emissions. | Ear Hear | 1999 | https://conductscience.org/library/papers/10526861 | PubMed |
| 2 | 3606063 | Cumulative and acute toxicity of repeated high-dose tobramycin treatment in cystic fibrosis. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3606063 | PubMed |
| 3 | 18389279 | What's new in cystic fibrosis? From treating symptoms to correction of the basic defect. | Eur J Pediatr | 2008 | https://conductscience.org/library/papers/18389279 | PubMed |
| 4 | 2202080 | Aminoglycoside-induced ototoxicity. | Toxicol Lett | 1990 | https://conductscience.org/library/papers/2202080 | PubMed |
| 5 | 3945060 | Effects of mild and moderate hearing impairments on language, educational, and psychosocial behavior of children. | J Speech Hear Disord | 1986 | https://conductscience.org/library/papers/3945060 | PubMed |
| 6 | 21760512 | High-frequency pure-tone audiometry in children: a test-retest reliability study relative to ototoxic criteria. | Ear Hear | 2012 | https://conductscience.org/library/papers/21760512 | PubMed |
| 7 | 22698459 | Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy. | Clin Biochem | 2012 | https://conductscience.org/library/papers/22698459 | PubMed |
| 8 | 21265638 | Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: A study using extended high-frequency audiometry and distortion product otoacoustic emissions. | Int J Audiol | 2011 | https://conductscience.org/library/papers/21265638 | PubMed |
| 9 | 20189661 | Hearing loss in cystic fibrosis. | Int J Pediatr Otorhinolaryngol | 2010 | https://conductscience.org/library/papers/20189661 | PubMed |
| 10 | 9056039 | Comparison of distortion product OAE generation between a patient group requiring frequent gentamicin therapy and control subjects. | Br J Audiol | 1997 | https://conductscience.org/library/papers/9056039 | PubMed |
| 11 | 18753950 | Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss. | Ear Hear | 2008 | https://conductscience.org/library/papers/18753950 | PubMed |
| 12 | 2816859 | Aminoglycoside ototoxicity in cystic fibrosis. Evaluation by high-frequency audiometry. | Am J Dis Child | 1989 | https://conductscience.org/library/papers/2816859 | PubMed |
| 13 | 17308839 | Auditory monitoring in ototoxicity. | Braz J Otorhinolaryngol | 2006 | https://conductscience.org/library/papers/17308839 | PubMed |
| 14 | 22744939 | The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy. | Pediatr Blood Cancer | 2013 | https://conductscience.org/library/papers/22744939 | PubMed |
| 15 | 12907047 | The prevalence of neurosensorial hearing loss among cystic fibrosis patients from Hospital de Clínicas de Porto Alegre. | Int J Pediatr Otorhinolaryngol | 2003 | https://conductscience.org/library/papers/12907047 | PubMed |
| 16 | 3311531 | Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/3311531 | PubMed |
| 17 | 16801404 | Absence of cochleotoxicity measured by standard and high-frequency pure tone audiometry in a trial of once- versus three-times-daily tobramycin in cystic fibrosis patients. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/16801404 | PubMed |
| 18 | 17401008 | Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17401008 | PubMed |
| 19 | 1583319 | High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity. | J Infect Dis | 1992 | https://conductscience.org/library/papers/1583319 | PubMed |
| 20 | 11843723 | Otoacoustic emissions for monitoring aminoglycoside-induced ototoxicity in children with cystic fibrosis. | Arch Otolaryngol Head Neck Surg | 2002 | https://conductscience.org/library/papers/11843723 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38333844 | Aminoglycoside-induced sensorineural hearing loss in pediatric cystic fibrosis patients: A retrospective cohort study. | Heliyon | 2024 | https://conductscience.org/library/papers/38333844 | PubMed |
| 37895824 | Aminoglycosides-Related Ototoxicity: Mechanisms, Risk Factors, and Prevention in Pediatric Patients. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37895824 | PubMed |
| 37356412 | A longitudinal study of the peripheral and central auditory pathways in individuals with acute lymphoid leukemia. | Clinics (Sao Paulo) | 2023 | https://conductscience.org/library/papers/37356412 | PubMed |
| 34234249 | Detection of unknown ototoxic adverse drug reactions: an electronic healthcare record-based longitudinal nationwide cohort analysis. | Sci Rep | 2021 | https://conductscience.org/library/papers/34234249 | PubMed |
| 33465313 | Functional Impacts of Aminoglycoside Treatment on Speech Perception and Extended High-Frequency Hearing Loss in a Pediatric Cystic Fibrosis Cohort. | Am J Audiol | 2021 | https://conductscience.org/library/papers/33465313 | PubMed |
| 29791559 | Sequential analysis as a tool for detection of amikacin ototoxicity in the treatment of multidrug-resistant tuberculosis. | J Bras Pneumol | 2018 | https://conductscience.org/library/papers/29791559 | PubMed |
| 29471610 | Ototoxicity: A Challenge in Diagnosis and Treatment. | J Audiol Otol | 2018 | https://conductscience.org/library/papers/29471610 | PubMed |
| 28238634 | The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis. | J Cyst Fibros | 2017 | https://conductscience.org/library/papers/28238634 | PubMed |
| 27894912 | Hearing thresholds at high frequency in patients with cystic fibrosis: a systematic review. | Braz J Otorhinolaryngol | 2017 | https://conductscience.org/library/papers/27894912 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CFTR | 1080 | PubTator's text mining | https://conductscience.org/library/genes/1080 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26480907
GET https://conductscience.org/api/papers/v1/26480907/references?page=2